Advisor Group Holdings, Inc. Roivant Sciences Ltd. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,211 shares of ROIV stock, worth $32,591. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,211
Previous 3,081
4.22%
Holding current value
$32,591
Previous $35,000
5.71%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
330Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$668 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$630 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$485 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$447 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$359 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...